文献速递胸部CT

小气道病变与肺气肿和吸烟者CT支气管扩张及慢阻肺未来急性加重相关:COPDGene队列研究结果

Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort.
PubMed 文献 · Radiology · 2021-06-22

在COPDGene队列中,对387例CT检出支气管扩张的重度吸烟者进行9年随访,小气道病变高负荷(≥15.6%)与肺气肿高负荷(≥5%)均与每年急性加重次数增多相关(RR分别为1.89和1.37);在符合慢阻肺标准的亚组中结果类似。

要点

  • CT支气管扩张吸烟者中,小气道病变≥15.6%者每年急性加重次数约为低负荷者的1.89倍。
  • 肺气肿≥5%者每年急性加重次数约为低负荷者的1.37倍,两指标均与未来急性加重独立相关。
  • 在符合慢阻肺标准的支气管扩张患者中,小气道病变与肺气肿高负荷仍与急性加重增多相关。

核心结论

  • 在CT检出支气管扩张且符合慢阻肺标准的吸烟者中,肺实质与小气道结构损伤与每年急性加重次数增多相关。

研究设计与样本

  • COPDGene队列研究,2009年7月至2018年,纳入737例现吸烟或既往重度吸烟者,其中387例CT检出支气管扩张,采用参数反应图法定量小气道病变与肺气肿,急性加重经每半年随访前瞻性评估。

诊断标准与关键数值

  • 小气道病变高负荷定义为≥15.6%,肺气肿高负荷定义为≥5%;高小气道病变负荷与每年急性加重次数增多的RR为1.89(95%CI:1.54,2.33),高肺气肿负荷的RR为1.37(95%CI:1.13,1.66),两者P≤.001。

临床应用与阅片要点

  • 阅片时可关注CT支气管扩张吸烟者的小气道病变与肺气肿定量负荷,高负荷(小气道病变≥15.6%、肺气肿≥5%)提示未来急性加重次数可能更多。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Chronic obstructive pulmonary disease (COPD) and bronchiectasis can overlap and share pathologic features, such as small airway disease (SAD). Whether the presence of SAD and emphysema in smokers with CT-derived bronchiectasis is associated with exacerbations is unknown. Purpose To assess whether SAD and emphysema in smokers with CT-derived bronchiectasis are associated with future exacerbations. Materials and Methods SAD and emphysema were quantified using the parametric response map method in former and current heavy smokers with and without bronchiectasis at CT from the COPDGene Study (from July 2009 to July 2018). Exacerbations were prospectively assessed through biannual follow-up. An exacerbation was defined as an increase in or new onset of respiratory symptoms treated with antibiotics and/or corticosteroids. Severe exacerbations were defined as those that required hospitalization. The association of a high burden of SAD (≥15.6%) and high burden of emphysema (≥5%) at CT with exacerbations was assessed with generalized linear mixed models. Results Of 737 participants, 387 (median age, 64 years [interquartile range, 58-71 years]; 223 women) had CT-derived bronchiectasis. During a 9-year follow-up, after adjustment for age, sex, race, body mass index, current smoking status, pack-years, exacerbations before study entry, forced expiratory volume in 1 second, or FEV1, and bronchiectasis severity CT score, high burden of SAD and high burden of emphysema were associated with a higher number of exacerbations per year (relative risk [RR], 1.89 [95% CI: 1.54, 2.33] and 1.37 [95% CI: 1.13, 1.66], respectively; P ≤ .001 for both). Results were comparable among participants with bronchiectasis meeting criteria for COPD (n = 197) (RR, 1.67 [95% CI: 1.23, 2.27] for high burden of SAD and 1.51 [95% CI: 1.20, 1.91] for high burden of emphysema; P ≤ .001 for both). Conclusion In smokers with CT-derived bronchiectasis and chronic obstructive pulmonary disease, structural damage to lung parenchyma and small airways was associated with a higher number of exacerbations per year. Clinical trial registration no. NCT00608764 © RSNA, 2021.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Maselli DJ, Yen A, Wang W, et al. Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort. Radiology. 2021. PMID: 34156303. doi:10.1148/radiol.2021204052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。